Relapse activity after assisted reproductive technology treatments in women with multiple sclerosis: a nationwide cohort study in Denmark
Open Access
- 20 October 2025
- journal article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 97 (1) , 44-49
Abstract
Background Evidence on relapse activity in relapsing-remitting multiple sclerosis (RRMS) after assisted reproductive technology (ART) treatment differs. We investigated whether relapse activity increased after ART initiation. Methods Women with RRMS from the Danish MS Registry who underwent ART treatment from 1995 to 2018 were eligible. The annualised relapse rate (ARR) and corresponding 95% CI at 3 and 9 months post-ART initiation versus 12 months pre-ART were investigated using a negative binomial regression model. Analyses were stratified for live births within 12 months post-ART and disease-modifying therapy (DMT) use pre-ART. Clinical and demographic factors associated with relapse risk were identified. Results At ART initiation, 162 women, median age 33 years (IQR: 30–37), median Expanded Disability Status Scale score 1.5 (IQR: 1.0–2.5) were included; 55 (34.0%) were exposed to DMT. 27 relapses were recorded (ARR (95% CI) 0.17 (0.11 to 0.26)) at 12 months pre-ART; 7 relapses and 0.17 (0.08 to 0.36) at 3 months post-ART initiation, and 16 relapses and 0.13 (0.08 to 0.23) at 9 months post-ART initiation. When stratified by ART outcomes, relapse counts in subgroups became small. Women continuing DMT at ART initiation showed a statistically non-significant increase in ARR at 3 months post-ART. Conclusions Women with RRMS in Denmark did not, on average, have increased relapse activity at 3 and 9 months post-ART initiation compared with 12 months pre-ART. Women with disease activity pre-ART initiation may have a potentially elevated relapse risk post-ART.Keywords
Funding Information
- Merck (10.13039/100009945)
This publication has 31 references indexed in Scilit:
- Multiple sclerosis: Pregnancy, fertility, and assisted reproductive technology–a reviewMultiple Sclerosis and Related Disorders, 2024
- Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple SclerosisCNS Drugs, 2023
- Assisted reproductive technology treatment and risk of multiple sclerosis – a Danish cohort studyFertility and Sterility, 2022
- The Danish National Register of assisted reproductive technology: content and research potentialsEuropean Journal of Epidemiology, 2021
- Live birth rates, infertility diagnosis, and infertility treatment in women with and without multiple sclerosis: Data from an administrative claims databaseMultiple Sclerosis and Related Disorders, 2020
- The Danish Multiple Sclerosis RegistryBrain and Behavior, 2020
- Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based reviewMultiple Sclerosis and Related Disorders, 2019
- The Danish Medical Birth RegisterEuropean Journal of Epidemiology, 2018
- Increase in multiple sclerosis activity after assisted reproduction technologyAnnals of Neurology, 2012
- Increased MS relapse rate during assisted reproduction techniqueJournal of Neurology, 2008